HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ji-Young Kim Selected Research

isobutyroylshikonin

11/2008Shikonin, acetylshikonin, and isobutyroylshikonin inhibit VEGF-induced angiogenesis and suppress tumor growth in lewis lung carcinoma-bearing mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ji-Young Kim Research Topics

Disease

50Neoplasms (Cancer)
02/2022 - 01/2008
12Parkinson Disease (Parkinson's Disease)
11/2018 - 01/2008
11Inflammation (Inflammations)
01/2022 - 11/2011
10Leukemia
01/2022 - 03/2008
10Breast Neoplasms (Breast Cancer)
06/2021 - 01/2007
9Neoplasm Metastasis (Metastasis)
01/2021 - 01/2008
7Graves Ophthalmopathy
01/2022 - 01/2018
7Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 06/2014
6Chromosome Aberrations (Chromosome Abnormalities)
01/2018 - 01/2007
5Fibrosis (Cirrhosis)
01/2022 - 04/2004
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2021 - 08/2015
5Ankylosing Spondylitis
01/2021 - 10/2011
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 05/2006
4Pain (Aches)
04/2021 - 12/2008
4Cognitive Dysfunction
10/2019 - 03/2012
3Ovarian Neoplasms (Ovarian Cancer)
06/2022 - 04/2012
3Hyperglycemia
02/2022 - 03/2018
3Lung Neoplasms (Lung Cancer)
01/2022 - 08/2019
3Obesity
10/2021 - 04/2015
3Carcinoma (Carcinomatosis)
02/2021 - 11/2015
3Alzheimer Disease (Alzheimer's Disease)
10/2019 - 02/2014
3Body Weight (Weight, Body)
05/2019 - 09/2014
3Emphysema
02/2017 - 09/2014
3Pneumonia (Pneumonitis)
01/2017 - 01/2009
3Carcinogenesis
01/2017 - 03/2008
3Stomach Neoplasms (Stomach Cancer)
10/2016 - 01/2008
3Adenocarcinoma
10/2016 - 01/2008
3Infections
09/2009 - 12/2006
2Type 2 Diabetes Mellitus (MODY)
02/2022 - 10/2012
2Stroke (Strokes)
01/2022 - 06/2014
2Hemorrhage
01/2022 - 12/2011
2Dermatitis
05/2020 - 06/2015
2Colonic Neoplasms (Colon Cancer)
01/2019 - 01/2010
2Multiple Myeloma
11/2018 - 03/2008
2Nervous System Diseases (Neurological Disorders)
07/2018 - 01/2013
2Melanoma (Melanoma, Malignant)
01/2018 - 01/2015
2Necrosis
01/2018 - 05/2016
2Mental Disorders (Mental Disorder)
09/2017 - 03/2012
2Cardiovascular Diseases (Cardiovascular Disease)
04/2017 - 04/2008
2Chronic Obstructive Pulmonary Disease (COPD)
01/2017 - 10/2016
2Prostatic Neoplasms (Prostate Cancer)
08/2016 - 05/2014
2Insulin Resistance
06/2016 - 04/2015
2Hypoxia (Hypoxemia)
03/2016 - 07/2015
2Autoimmune Diseases (Autoimmune Disease)
06/2015 - 10/2011
2Dementia (Dementias)
06/2014 - 06/2013
2Rheumatoid Arthritis
06/2014 - 03/2008

Drug/Important Bio-Agent (IBA)

22Proteins (Proteins, Gene)FDA Link
01/2022 - 05/2006
7Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2005
7Pharmaceutical PreparationsIBA
01/2022 - 06/2015
6EnzymesIBA
01/2020 - 01/2013
6Messenger RNA (mRNA)IBA
01/2019 - 03/2017
5LipidsIBA
05/2020 - 12/2012
4Therapeutic UsesIBA
01/2022 - 07/2015
4CytokinesIBA
01/2022 - 06/2015
4RNA (Ribonucleic Acid)IBA
11/2021 - 03/2011
4Biological ProductsIBA
01/2019 - 02/2009
4Histone MethyltransferasesIBA
11/2018 - 03/2008
4Peptides (Polypeptides)IBA
01/2018 - 08/2013
4CateninsIBA
07/2017 - 07/2015
4Pancreatic Elastase (Elastase)IBA
02/2017 - 09/2014
4Levodopa (L Dopa)FDA LinkGeneric
06/2014 - 01/2008
3Glucose (Dextrose)FDA LinkGeneric
02/2022 - 06/2016
3CollagenIBA
01/2022 - 04/2004
3Interleukin-6 (Interleukin 6)IBA
01/2022 - 01/2017
3Cisplatin (Platino)FDA LinkGeneric
07/2021 - 04/2012
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 12/2014
3Tyrosine (L-Tyrosine)FDA Link
01/2020 - 10/2004
3Amyloid (Amyloid Fibrils)IBA
10/2019 - 06/2013
3ErbB Receptors (EGF Receptor)IBA
08/2019 - 01/2010
3Histones (Histone)IBA
08/2016 - 03/2008
3Lysine (L-Lysine)FDA Link
08/2016 - 03/2008
3AntioxidantsIBA
06/2016 - 02/2014
3Neuroprotective AgentsIBA
06/2014 - 10/2003
3ChromatinIBA
09/2012 - 04/2009
3CaspasesIBA
03/2012 - 10/2004
2Annexin A5IBA
09/2021 - 10/2004
2Analgesics (Analgesic Drugs)IBA
04/2021 - 01/2021
2STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
01/2021 - 01/2021
2Indicators and Reagents (Reagents)IBA
05/2020 - 01/2008
2ImmunosorbentsIBA
01/2020 - 10/2016
2Melanins (Melanin)IBA
01/2018 - 01/2015
2NeuropilinsIBA
01/2018 - 05/2016
2SmokeIBA
10/2016 - 07/2015
2Threonine (L-Threonine)FDA Link
08/2016 - 05/2014
2AndrogensIBA
08/2016 - 05/2014
2Angiogenesis InhibitorsIBA
07/2015 - 11/2012
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2015 - 11/2008
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2015 - 11/2012
2piperlongumineIBA
04/2015 - 12/2014
2Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
09/2014 - 11/2012
2Taurocholic Acid (Sodium Taurocholate)IBA
09/2014 - 11/2012
2LeptinIBA
06/2014 - 08/2012
2Amyloid beta-PeptidesIBA
06/2014 - 03/2014

Therapy/Procedure

17Therapeutics
01/2022 - 01/2010
9Deep Brain Stimulation
11/2018 - 04/2008
3Radiotherapy
09/2019 - 01/2007
3Drug Therapy (Chemotherapy)
04/2016 - 09/2011
2Precision Medicine
01/2022 - 08/2019
2Neoadjuvant Therapy
01/2021 - 06/2011
2Cell- and Tissue-Based Therapy (Cell Therapy)
09/2020 - 01/2017